Structural genomic variation in childhood epilepsies with complex phenotypes.

Area of Science:

• Genetics
• Neurology
• Medical Diagnostics

Background:

• Epilepsies have a suspected genetic basis, with copy number variations (CNVs) identified as significant risk factors.
• The specific role of CNVs in epilepsies presenting with complex phenotypes remains largely unknown.
• Understanding genetic contributions is crucial for diagnosing and managing diverse epilepsy cases.

Purpose of the Study:

• To investigate the role and frequency of CNVs in patients with unclassified epilepsies and complex phenotypes.
• To determine if CNV detection rates differ based on neuroimaging or clinical features.
• To assess the diagnostic utility of genome-wide CNV screening in this patient cohort.

Main Methods:

• Clinically evaluated 222 patients from three European countries with complex epilepsy phenotypes.
• Screened patients for rare CNVs using genome-wide methods.
• Analyzed magnetic resonance imaging (MRI) findings and patient characteristics, including dysmorphic features and congenital anomalies.

Main Results:

• Identified 88 rare CNVs in 71 out of 222 patients (31.9%).
• Found no statistical difference in structural or de novo variant frequency between patients with or without MRI abnormalities.
• Observed a higher likelihood of carrying a rare CNV in patients with dysmorphic features.

Conclusions:

• Genome-wide screening for rare CNVs can identify genetic etiologies in a wider range of epilepsies than previously thought.
• CNV screening is valuable for patients with complex phenotypes, including those with brain anomalies visible on MRI.
• Integrating genome-wide CNV analysis into routine diagnostics can aid in managing childhood epilepsies.